Navigation Links
Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
Date:10/23/2008

HDACs appear to promote tighter winding of DNA around these proteins, leading to reduced access by gene transcription factors. This results in decreased expression of proteins involved in cell differentiation, cell cycle arrest and apoptotic elimination of damaged cells -- all of which contribute to the development of cancer. HDAC inhibitors are able to restore expression of tumor suppressor genes in a highly selective manner. Treatment with HDAC inhibitors also leads, indirectly, to inhibition of the expression of angiogenesis factors, helping to choke off the blood supply to tumors.

Although significant preclinical and clinical activity has been observed with HDAC inhibitors, most have characteristics which may limit their potential for clinical success or broad applicability. In contrast, Chidamide/HBI-8000 has selectivity, potency, PK and side effect profiles that make it ideal for use as a stand-alone therapeutic, as well as in combination with a wide variety of marketed anti-tumor agents.

HUYA's Integrated Co-development Model (ICM)

The global pharmaceutical industry faces a pressing need for new untapped sources of pre-clinical and clinical stage compounds for the drug development process. HUYA was one of the first companies to recognize China's potential to help meet this need through its burgeoning biotechnology industry and world-class talent pool. HUYA has pioneered an innovative approach -- the HUYA Integrated Co-development Model -- for partnering with Chinese research institutions and pharmaceutical companies. HUYA identifies and licenses the most promising pre-clinical and clinical stage compounds in China, leverages and extends the research efforts of its Chinese partners, and provides a bridge into the Western development process and biopharma market.

Because the compounds have already been validated through a rigorous discovery, selection and development process in China, this model streamlines and accelerates developmen
'/>"/>

SOURCE HUYA Bioscience International; Chipscreen Biosciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: The Market for ... The European, Middle Eastern and African ... devices. As part of its coverage, this study: ... on the EMEA medical device markets and estimates ...
(Date:8/20/2014)... , Aug. 20, 2014 ... research report is available in its catalogue: ... Records http://www.reportlinker.com/p0833392/EMR-2014-The-Market-for-Electronic-Medical-Records.html ... for electronic medical records (EMR) for nearly a ... report of our findings. Our report has become ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5EMR 2014: The Market for Electronic Medical Records 2EMR 2014: The Market for Electronic Medical Records 3EMR 2014: The Market for Electronic Medical Records 4EMR 2014: The Market for Electronic Medical Records 5EMR 2014: The Market for Electronic Medical Records 6EMR 2014: The Market for Electronic Medical Records 7EMR 2014: The Market for Electronic Medical Records 8
... April 25, 2011 The 2010 Pharmacy Today ... American Pharmacists Association , reveals pharmacists believe that ... was recommended by their pharmacist, 92% of pharmacists walk ... a product selection and the average patient consult takes ...
... Scientific Corporation (NYSE: BSX ) today ... and launch of the ION™ Paclitaxel-Eluting Platinum Chromium ... technology.  The ION Stent System incorporates a unique ... stenting and intended to improve the acute performance ...
Cached Medicine Technology:Pharmacists Offer Guidance on Top Over-The-Counter Medications 2Pharmacists Offer Guidance on Top Over-The-Counter Medications 3Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 2Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 3Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 4Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System 5
(Date:8/20/2014)... Angeles, CA (PRWEB) August 20, 2014 ... it is bringing on Wrench Advisors as a ... tasks including international large accounts. , As Wrench ... sales consultants can help your organization plan and ... executives and global distribution channels. Our experience developing ...
(Date:8/20/2014)... 20, 2014 Business owners looking for ways ... a big, lasting impact – should check out the latest ... http://www.PerWickstrom.com . , The new blog post, which is ... Your Business,” highlights that:, , Opportunities for ... and therefore it’s essential to be alert and focused. , ...
(Date:8/20/2014)... TX (PRWEB) August 20, 2014 Texas Medical ... new study. The study will help test the effectiveness of ... suffer from high cholesterol may be eligible to participate in ... much cholesterol in the blood can lead to cardiovascular disease, ... Lowering cholesterol can help reduce the risk of heart disease ...
(Date:8/20/2014)... the 100th anniversary of a revolutionary technique that underpins ... (C&EN) magazine last week released a special edition ... tantalizing glimpse of its future. C&EN is the weekly ... world,s largest scientific society. , The technique got its ... first paper on X-ray diffraction from a crystal in ...
(Date:8/20/2014)... services from the Veterans Health Administration finds general satisfaction, ... studied. , The RAND Corporation study, conducted in 2008 ... disorder were less satisfied than other veterans who received ... were less likely than others to report that staff ... findings, published in the journal Psychiatric Services , ...
Breaking Medicine News(10 mins):Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:Per Wickstrom’s Latest Blog Post Focuses on Small Changes that Can Have a Big Impact on Business 2Health News:Texas Medical Research Associates Announce New Study 2Health News:Survey finds veterans generally satisfied with mental health care 2
... HealthDay Reporter , WEDNESDAY, July 20 (HealthDay News) ... rashes, but the similarities between the two common, distressing ... patients suffering from both ailments (a very rare phenomenon), ... responses that prompt skin flare-ups for both diseases. ...
... Mann HealthDay Reporter , WEDNESDAY, July 20 (HealthDay ... may be heating up. New technology promises to cut costs ... all of your genes and potentially provide a personalized report ... The human genome was first mapped in 2001 and ...
... health, alleviate hunger, raise living standards and empower women ... to play. Jagdev Sharma, a researcher ... Arizona State University,s Biodesign Institute has been investigating the ... villagers in rural Uganda. He reports his findings this ...
... the Breast Health Center at Women & Infants Hospital ... earn a 2011 Breast Cancer Symposium Merit Award from ... Clinical Oncology (ASCO). The award, which recognizes researchers, ... Shannon MacLaughlan, MD, who is also affiliated with The ...
... injuring a muscle through an accident like falling off a ... serious complication. Their muscles start growing bones. ... there was no treatment. But now, research from Northwestern University ... at the University of Pennsylvania shows that a neuropeptide in ...
... American Society for Radiation Oncology (ASTRO) has awarded ... Faculty Career Research Training Award and the Residents/Fellows ... were selected by ASTRO,s Research Evaluation Committee. ... awarded to stimulate interest in radiation research early ...
Cached Medicine News:Health News:Scientists Close in on Origins of Psoriasis, Eczema 2Health News:Scientists Close in on Origins of Psoriasis, Eczema 3Health News:Cheaper DNA Sequencing Coming Closer 2Health News:Cheaper DNA Sequencing Coming Closer 3Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 2Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 3Health News:When injured muscles mistakenly grow bones 2
Ahmed Glaucoma Valve (small size)....
... established. Provides a robust and durable drainage ... on the globe. Pressure Ridge Molteno Implants ... by Tenons tissue, acts as a Pressure ... range of implants allows the surgeon to ...
... a robust and durable drainage system. Preplaced ... globe. Pressure Ridge Molteno Implants have a ... tissue, acts as a Pressure sensitive biological ... implants allows the surgeon to choose the ...
... Baerveldt Glaucoma Implants feature a low ... and reduced complications. The single-quadrant insertion is ... area seton plate to be installed with ... patented fenestrations of the Baerveldt implant were ...
Medicine Products: